Therabis Debuts New Product at Largest Pet Industry Trade Show in North America

Published: August 19, 2019

Therabis Debuts New Product at Largest Pet Industry Trade Show in North America

Dixie Brands Inc., one of the cannabis industry’s leading consumer packaged goods (“CPG”) companies, announced a number of new product and marketing initiatives from its pet wellness subsidiary, Therabis LLC.

Therabis, a research-driven pioneer in the broad-spectrum hemp-based pet supplement market, continued its heritage of vet-inspired innovation at SuperZoo 2019, the preeminent national show for pet retailers, announcing the launch of its new Mobility soft chew for dogs. Designed to promote joint health and a healthy inflammatory system in dogs, the new soft chew also showcases the new brand livery and updated packaging unveiled at the trade show and being rolled out across the Therabis portfolio.

In addition to the new Mobility soft chews, Therabis recently introduced a new increased strength Veterinary Formula distributed through Vedco, the nation’s largest distributor for vets. The formula features the brand’s Mobility and Calming products with higher concentrations of naturally occurring cannabinoids and uses unique active ingredients to help support specific aspects of pet health. Therabis Veterinary Formula is now offered through veterinary hospitals and clinics across the country.

Backed by 25 years of veterinary experience Dr. Stephen M. Katz founded Therabis with the goal of relieving some of the most common pet ailments with the proven benefits of natural ingredients. Each Therabis product is formulated with only the best nutritionally rich and naturally derived ingredients. The broad-spectrum hemp-infused supplements combine naturally occurring cannabidiol, green-lipped mussel and specific vitamins and minerals, like vitamin C and chromium for dogs and L-Taurine for cats. These fast-acting, powerful supplements are easy to administer and target specific conditions including joint mobility, anxiety and skin irritation.

“Throughout the years, Therabis continues to receive wonderful responses about our indication-specific formulas from satisfied consumers sharing their heart-warming success stories about their pets’ improved health,” said Bob Rubin, President of Therabis. “Hearing this positive feedback from people who buy our products is so fulfilling – there’s no better feeling than knowing we are making a difference in the lives of these animals and their owners.”

Therabis’ full portfolio of indication-specific products – Calming, Mobility & Stop the Itch – are available for purchase from select retailers nationwide, in the offices of trusted veterinary professionals and online at the newly updated For more information on Therabis, visit the company’s website and follow along on Instagram, @therabispet.